Skip to content

Capsule Endoscopy Delivery at sCale Through Enhanced AI anaLysis Study

Capsule Endoscopy Delivery at sCale Through Enhanced AI anaLysis Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06008847
Acronym
CESCAIL
Enrollment
720
Registered
2023-08-24
Start date
2022-02-09
Completion date
2024-10-16
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Cancer

Keywords

bowel, cancer, AI

Brief summary

The CESCAIL study tests the use of Artificial Intelligence (AI) on a video taken from a minimally-invasive imaging device, to improve efficiency and accuracy of the detection of polyps, which are little outgrowths within the lining of the bowel.

Detailed description

Participants will be continuing to follow their standard care pathway, and there are no additional requirements of the participants other than providing consent for their pseudonymised capsule video and data to be used to test the AI system. The participant's final diagnosis will only be determined by the clinician's standard analysis pathway and not influenced by the AI enabled analysis pathway. All data is de-identified before a video is created and re-identified only once the standard final report is signed-off by the referring clinician. Therefore, the risk of patient harm due to exposed data is minimised.

Interventions

None listed

Sponsors

University Hospitals Coventry and Warwickshire NHS Trust
Lead SponsorOTHER
University of Barcelona
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 or over * Patients who have been selected by overseeing clinician meeting NHS England criteria to undergo colon capsule endoscopy as part of their standard of care

Exclusion criteria

* Patients unable to provide consent to take part in the study

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and specificity of polyp detection in AI enabled CCE reporting11 monthsSensitivity and specificity of polyp detection in AI enabled CCE reporting
Time taken to read video by clinicians and AI tool11 monthsTime taken to read video by clinicians and AI tool

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026